Caris Life Sciences：上修財測，估值仍具吸引力 (NASDAQ:CAI)
· seekingalpha.com
Caris Life Sciences (CAI) 第二季財報優於預期，並上修年度指引、利潤率擴張，以及推出 Caris Detect。
My name is María Fernanda and I'm currently studying an MBA. My inspiration investors are Warren Buffett, Peter Lynch and Terry Smith, so I look for quality co...